# A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics

Study · id `cardio:ct-nct01644201` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01644201](<https://clinicaltrials.gov/study/NCT01644201>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01644201

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 100 participants.

## Technical summary

Registry record NCT01644201. Randomized; quadruple masking; primary purpose treatment. Start 2012-10 (registry gives no type); primary completion 2016-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT01644201, source copy `cardio:ctgov-nct01644201-2021-02-11`, retrieved 2026-10-26)
- Start date: 2012-10 (registry gives no type) (ClinicalTrials.gov record NCT01644201, source copy `cardio:ctgov-nct01644201-2021-02-11`, retrieved 2026-10-26)
- Primary completion: 2016-11 (actual) (ClinicalTrials.gov record NCT01644201, source copy `cardio:ctgov-nct01644201-2021-02-11`, retrieved 2026-10-26)
- Completion: 2016-11 (actual) (ClinicalTrials.gov record NCT01644201, source copy `cardio:ctgov-nct01644201-2021-02-11`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01644201, source copy `cardio:ctgov-nct01644201-2021-02-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01644201-2021-02-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics
- Condition: Type II Diabetes Mellitus
- Condition: Obesity
- Intervention (Dietary supplement): PolyGlycopleX® - PGX®
- Intervention (Dietary supplement): Rice Flour (placebo)
- Lead sponsor: InovoBiologic Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of a functional fibre supplement on glycemic control when added to a year-long medically supervised weight management program in adults with type 2 diabetes (`cardio:pubmed-32642971`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c30a0af620e0537c8b21ffa0b6f4fff3367778cf377978c4f2635960c1eb17fd
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
